LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-17
Case ID: NM_005245.4_c.4516C_T_20261117_022451
Framework: ACMG/AMP 2015
Variant classification summary

NM_005245.4:c.4516C>T

FAT1  · NP_005236.2:p.(Arg1506Cys)  · NM_005245.4
GRCh37: chr4:187549725 G>A  ·  GRCh38: chr4:186628571 G>A
Gene: FAT1 Transcript: NM_005245.4
Final call
VUS
All criteria require review: For research and educational purposes only.
Gene
FAT1
Transcript
NM_005245.4
Protein
NP_005236.2:p.(Arg1506Cys)
gnomAD AF
0.00082529312776182 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
None of PS1, PM1, PM5, PP2, or BP1 can be concluded from the supplied evidence because the required same-residue pathogenic comparators, validated domain or hotspot route, gene-level missense mechanism, or truncating-variant predominance are not established.
2
No VCEP covers FAT1 in this case; the requested criteria were evaluated under generic ACMG/AMP 2015 definitions.
3
No exact-variant expert-panel ClinVar Pathogenic/Likely pathogenic or Benign/Likely benign classification was found, so PP5 and BP6 are not met.
4
FAT1 has no VCEP in this case, so generic ACMG/AMP rules govern.
5
The variant is missense; PP3 and BP4 therefore use the REVEL path only, with no cross-use of SpliceAI or BayesDel.
6
REVEL 0.341 is in the gray zone: below all PP3 thresholds and above all BP4 thresholds.
7
PP3 and BP4 are both applicable but not met; no other criteria were adjudicated.
Final determination: Under the generic ACMG/AMP 2015 fallback, no pathogenic, likely pathogenic, benign, or likely benign combination threshold is satisfied, so the variant is classified as VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not assessed Not assessed: no previously established pathogenic variant with the same Arg1506Cys amino-acid change was identified in the supplied evidence.
clinvar pm5_candidates PMID:25741868
PS2 Not assessed Not assessed: no documented proband de novo observation with confirmed maternity and paternity, disease phenotype, and absent family history.
PS3 Not assessed Not assessed: no variant-specific validated functional assay or reviewed functional result was available for FAT1 p.Arg1506Cys.
oncokb
PS4 Not assessed Not assessed: PMID:34598035 provides no variant-specific case/control counts, OR, or confidence interval needed to test OR >5.0 with a CI excluding 1.0.
PMID:34598035
PM1 Not assessed Not assessed: FAT1 R1506 has no supplied critical-domain evidence, no Cancer Hotspots result, and no demonstrated absence of benign variation.
hotspots cosmic PMID:25741868
PM2 Not met Not met: gnomAD v4.1 total AF is 0.000825293, above the generic PM2 supporting cutoff of 0.0001, with 1,332 observed alleles.
gnomad_v4 gnomad_v2
PM3 Not assessed Not assessed: no affected-proband observation, pathogenic partner allele, or parental/offspring testing establishes a recessive trans configuration.
clinvar PMID:25741868
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not assessed Not assessed: no different missense variant at Arg1506 is established as pathogenic in the supplied evidence.
pm5_candidates clinvar PMID:25741868
PM6 Not assessed Not assessed: no documented assumed de novo observation in a proband with a relevant disease phenotype or reported parental testing.
PP1 Not assessed Not assessed: no affected family members or variant-positive meioses are documented to evaluate co-segregation with disease.
PP2 Not assessed Not assessed: FAT1 missense mechanism and low benign-missense rate are not jointly established by the supplied evidence.
gnomad_v4 oncokb pvs1_gene_context PMID:25741868
PP3 Not met Not met: missense REVEL 0.341 is below the PP3 supporting threshold of 0.644.
revel PMID:25741868
PP4 Not assessed Not assessed: no patient phenotype or family-history information is available to determine whether it is highly specific for a single-gene disease.
PP5 Not met Not met: ClinVar reports the exact variant as Uncertain significance in six submissions with zero expert-panel classifications, not Pathogenic or Likely pathogenic.
clinvar
BA1 Not met Not met: gnomAD v4.1 grpmax FAF is 0.00099187, far below the generic BA1 threshold of 0.05, using 62,490 observed alleles.
gnomad_v4 gnomad_v2
BS1 Not met Not met: gnomAD v4.1 grpmax FAF is 0.00099187, below the generic BS1 threshold of 0.01, with 62,490 observed alleles.
gnomad_v4 gnomad_v2
BS2 Not assessed Not assessed: gnomAD reports zero homozygotes but does not establish healthy-adult status, inheritance model, or early-age full penetrance for FAT1 disease.
gnomad_v4 gnomad_v2
BS3 Not assessed Not assessed: no variant-specific validated functional assay or reviewed neutral result was available for FAT1 p.Arg1506Cys.
oncokb
BS4 Not assessed Not assessed: no tested affected relatives or genotype-negative affected family members are documented to demonstrate lack of segregation.
BP1 Not assessed Not assessed: FAT1 loss-of-function evidence is present, but predominance of truncating disease variants over missense variants is not established.
pvs1_gene_context PMID:25741868
BP2 Not assessed Not assessed: no evidence shows this variant in trans with a pathogenic dominant- disorder allele or in cis with any pathogenic allele.
clinvar PMID:25741868
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Not met Not met: missense REVEL 0.341 exceeds the BP4 supporting threshold of 0.29, so SpliceAI cannot substitute.
revel PMID:25741868
BP5 Not assessed Not assessed: no affected case is documented with this variant and an independently established alternate molecular basis for disease.
BP6 Not met Not met: ClinVar reports the exact variant as Uncertain significance in six submissions with zero expert-panel classifications, not Benign or Likely benign.
clinvar
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a missense variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.